Key facts
- This page summarizes M33 Growth I L.P.'s Form 4 filing for Oncology Institute, Inc. (TOI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Mar 2025, 19:36.
M33 Growth I L.P. - 26 Mar 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- TOI
- Reported as of
- 26 Mar 2025
- Net transaction value
- +$2,999,999
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2025, 19:36:47 UTC
- Prior SEC filing
- 22 Nov 2021
- Next SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gabriel Ling, Managing Member of M33 Growth I GP LLC, the general partner of M33 Growth I LP
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
M33 Growth I L.P. filed Form 4 for Oncology Institute, Inc. (TOI) on 28 Mar 2025.
Change
- Previous filing in this sequence was filed on 22 Nov 2021.
- Current net transaction value: +$2,999,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TOI
transaction
Common Stock
Award
- Transaction value
- $2,830,193
- Shares
- +2,716,898
- Change %
- +20%
- Price
- $1.04
- Shares after
- 16,420,701
- Date
- 26 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TOI
transaction
Derivative
Warrant to Purchase Shares of Common Stock
Award
- Transaction value
- $169,806
- Shares
- +1,358,449
- Change %
- Price
- $0.1250
- Shares after
- 1,358,449
- Date
- 26 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,358,449
- Exercise price
- $1.20
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP ("M33 LP") purchased an aggregate of 1,358,449 units ("Units") consisting of 2,716,898 shares of common stock and 1,358,449 warrants ("Warrants") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
Footnote F2
M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 LP ("M33 GP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.